Cargando…
Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets
Non-alcoholic fatty liver disease (NAFLD) and atherosclerosis (ATS) are worldwide known diseases with increased incidence and prevalence. These two are driven and are interconnected by multiple oxidative and metabolic functions such as lipotoxicity. A gamut of evidence suggests that sphingolipids (S...
Autores principales: | Tanase, Daniela Maria, Gosav, Evelina Maria, Petrov, Daniela, Jucan, Alina Ecaterina, Lacatusu, Cristina Mihaela, Floria, Mariana, Tarniceriu, Claudia Cristina, Costea, Claudia Florida, Ciocoiu, Manuela, Rezus, Ciprian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621166/ https://www.ncbi.nlm.nih.gov/pubmed/34829402 http://dx.doi.org/10.3390/diagnostics11112053 |
Ejemplares similares
-
The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)
por: Tanase, Daniela Maria, et al.
Publicado: (2020) -
The Predictive Role of the Biomarker Kidney Molecule-1 (KIM-1) in Acute Kidney Injury (AKI) Cisplatin-Induced Nephrotoxicity
por: Tanase, Daniela Maria, et al.
Publicado: (2019) -
Hypothyroidism-Induced Nonalcoholic Fatty Liver Disease (HIN): Mechanisms and Emerging Therapeutic Options
por: Tanase, Daniela Maria, et al.
Publicado: (2020) -
Role of Gut Microbiota on Onset and Progression of Microvascular Complications of Type 2 Diabetes (T2DM)
por: Tanase, Daniela Maria, et al.
Publicado: (2020) -
Oxidative Stress and NRF2/KEAP1/ARE Pathway in Diabetic Kidney Disease (DKD): New Perspectives
por: Tanase, Daniela Maria, et al.
Publicado: (2022)